

My Great Strides Story
Gretchen Nichting
Fundraising for Triangle Great Strides 2026
Gretchen Nichting
GREAT STRIDES, a Walk supporting the CF Foundation, will take place Saturday, May 16, 2026. We, along with other Teams of families, care providers, friends and spirited supporters will be “making strides”; we ask, if you are able, that you support our effort, and the 2026 GREAT STRIDES Walk.
Allison continues to love her job at Duke University Medical Center as a Pediatric nurse! She has successfully managed working 3- day, 12- hour shifts (alternating day and night shifts) as well as her health and CF regimen.
Since starting Trikafta (elexacaftor/ivacaftor/tezacaftor), a triple combination therapy available to treat patients who have at least one F508del mutation, which is estimated to represent 90% of the CF population) in September 2019, Allison has been very healthy. No hospitalizations since July 2019. Trikafta really has been a game changer for Allison and so many others fighting Cystic Fibrosis.
It has been a challenging and incredible journey since diagnosis March 1, 2001, learning and seeing very encouraging advances over the last 25years. With continued support, we are confident research will progress at a similar pace and the rarest CF gene mutations will be addressed, including Allison's.
Allison continues to love her job at Duke University Medical Center as a Pediatric nurse! She has successfully managed working 3- day, 12- hour shifts (alternating day and night shifts) as well as her health and CF regimen.
Since starting Trikafta (elexacaftor/ivacaftor/tezacaftor), a triple combination therapy available to treat patients who have at least one F508del mutation, which is estimated to represent 90% of the CF population) in September 2019, Allison has been very healthy. No hospitalizations since July 2019. Trikafta really has been a game changer for Allison and so many others fighting Cystic Fibrosis.
It has been a challenging and incredible journey since diagnosis March 1, 2001, learning and seeing very encouraging advances over the last 25years. With continued support, we are confident research will progress at a similar pace and the rarest CF gene mutations will be addressed, including Allison's.







Comments